Search

Filters
Clear All
  • 2
  • 11
  • 47

Phase

  • 7
  • 2
  • 16
  • 2
  • 16
  • 2
  • 15
  • 59
  • 3

Found 60 site-public-contact trials

A listing of site-public-contact medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A
Anita Turk, MD
18 years - 100 years
All genders
Phase 2
This study investigates the effects of combining investigational medications with standard chemotherapy for advanced biliary tract cancer. Biliary tract cancer is a type of cancer that affects the bile ducts, which are tubes that carry bile from the liver to the gallbladder and small intestine. The purpose of this study …
J
Jennifer King
18 years - 100 years
All genders
This study investigates the use of an investigational medication in combination with oral etoposide for patients with relapsed metastatic germ cell tumor (GCT). Germ cell tumors are a type of cancer that begins in the cells that give rise to sperm or eggs. This study is designed to find out …
P
Pravin Kaumaya
18 years - 100 years
All genders
Phase 1
This study investigates an investigational vaccine for people with HER2 positive breast cancer. HER2 positive breast cancer is a type of cancer where there are too many HER2 proteins on the surface of the cancer cells, which can make the cancer grow faster. The purpose of this study is to …
S
Samantha Armstrong
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started to other places in the …
R
Rafat Abonour, MD
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory …
S
Susan Ballinger
18 years - 100 years
All genders
Phase 3
This study investigates the effects of an investigational medication on appetite loss in patients with advanced cancer. Advanced cancer means the cancer has spread to other parts of the body. The purpose of this study is to compare the investigational medication with another usual medication to see which one is …
R
Rita Assi
18 years - 100 years
All genders
Phase 2
This study investigates treatments for older adults with a type of blood cancer called acute myeloid leukemia (AML) that has a specific mutation known as FLT3. The purpose is to compare different treatments to see which is more effective. AML is a cancer of the blood and bone marrow, where …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 1
This study investigates the safety and effects of a combination treatment for locally advanced or metastatic breast cancer. Breast cancer is a disease where cells in the breast grow out of control. This study looks at an investigational medication made from the patient's own T cells, which are a type …
T
Tareq Salous
18 years - 100 years
All genders
Phase 2
This study investigates muscle-invasive bladder cancer, a type of cancer that grows into the muscle layer of the bladder. The purpose is to see how well an investigational medication combined with another treatment works for this type of cancer. The study involves patients with muscle-invasive bladder cancer receiving treatment and …
N
Nabil Adra, MD
15 years - 100 years
All genders
Phase 1
This study investigates the safety and tolerability of an investigational medication in people with advanced solid tumors. Advanced solid tumors are cancers that have spread and are difficult to treat. The purpose of this study is to find out if the investigational medication is safe and to determine the best …